2015
Human Immunodeficiency Virus and Heart Failure in Low- and Middle-Income Countries
Bloomfield GS, Alenezi F, Barasa FA, Lumsden R, Mayosi BM, Velazquez EJ. Human Immunodeficiency Virus and Heart Failure in Low- and Middle-Income Countries. JACC Heart Failure 2015, 3: 579-590. PMID: 26251085, PMCID: PMC4530470, DOI: 10.1016/j.jchf.2015.05.003.Peer-Reviewed Original ResearchMeSH KeywordsAge FactorsAntiretroviral Therapy, Highly ActiveCause of DeathChronic DiseaseCross-Sectional StudiesDeveloped CountriesDeveloping CountriesForecastingHeart FailureHIV InfectionsHumansInternationalityLife ExpectancyRisk FactorsConceptsHuman immunodeficiency virusHeart failureMiddle-income countriesImmunodeficiency virusChronic diseasesBurden of HIVTraditional cardiovascular risk factorsCommon cardiac diagnosesCardiovascular risk factorsLarge observational studiesLife expectancySuccessful combination therapyCare of peopleAntiretroviral therapyClinical characteristicsTreatment patternsSociety guidelinesCombination therapyRisk factorsClinical studiesObservational studyDiagnostic criteriaCardiac diagnosisHigh mortalityCardiac glycosides
2014
HIV and Noncommunicable Cardiovascular and Pulmonary Diseases in Low- and Middle-Income Countries in the ART Era
Bloomfield GS, Khazanie P, Morris A, Rabadán-Diehl C, Benjamin LA, Murdoch D, Radcliff VS, Velazquez EJ, Hicks C. HIV and Noncommunicable Cardiovascular and Pulmonary Diseases in Low- and Middle-Income Countries in the ART Era. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2014, 67: s40-s53. PMID: 25117960, PMCID: PMC4133739, DOI: 10.1097/qai.0000000000000257.Peer-Reviewed Original ResearchMeSH KeywordsAnti-Retroviral AgentsAntiretroviral Therapy, Highly ActiveCardiovascular DiseasesDeveloping CountriesHIV InfectionsHumansLung DiseasesResearchRisk FactorsConceptsHIV-positive patientsAntiretroviral therapyHIV infectionMiddle-income countriesPulmonary diseaseCoronary artery disease/myocardial infarctionLong-term HIV infectionEffective antiretroviral therapyHIV-seropositive patientsLong-term morbidityPulmonary arterial hypertensionObstructive lung diseaseHIV-positive personsLong-term outcomesChronic noncommunicable diseasesEffective prevention strategiesPotential adverse effectsPulmonary complicationsArterial hypertensionHeart failureLung diseasePulmonary conditionsMyocardial infarctionEarly recognitionART era